LMR Partners’s CVS Health CVS Stock Holding History

LMR Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,200	Closed	-$420K	–	1432
2025 Q1	$420K	Buy	+6,200	New	+$371K	﹤0.01%	944

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LMR Partners's CVS Position: Q2 2022 in Review

LMR Partners sold out of CVS Health (CVS) in Q2 2022, closing a stake of 12,307 shares — an estimated $1.25M sold.

LMR Partners first reported a position in CVS in Q1 2014 and held it in 14 quarters. The position peaked at $6.09M in Q1 2017. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

LMR Partners reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
LMR Partners sold 12,307 CVS Health shares in Q2 2022, an estimated $1.25M.
LMR Partners first reported a position in CVS Health in Q1 2014 and held it in 14 quarters.
LMR Partners's CVS Health position peaked at $6.09M in Q1 2017.
2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on LMR Partners's 13F filing for Q2 2022, filed 15 Aug 2022.